Evaluation of pharmacokinetic parameters and dipeptidyl peptidase-4 inhibition following single doses of sitagliptin in healthy, young Japanese males

When and how to evaluate mildly elevated liver enzymes in apparently healthy patients

(2010) G. ARAGON et al.   CLEVELAND CLINIC JOURNAL OF MEDICINE

Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes

(2010) Debora Williams-Herman et al.   BMC Endocrine Disorders

Sitagliptin 100 mg daily effect on DPP-4 inhibition and compound-specific glycemic improvement

(2009) M. Alba et al.   CURRENT MEDICAL RESEARCH AND OPINION

Pharmacogenetics of Membrane Transporters: An Update on Current Approaches

(2009) Tristan M. Sissung et al.   MOLECULAR BIOTECHNOLOGY

Sitagliptin, a DPP-4 inhibitor for the treatment of patients with type 2 diabetes: a review of recent clinical trials

(2008) Avraham Karasik et al.   CURRENT MEDICAL RESEARCH AND OPINION

Determination of sitagliptin in human urine and hemodialysate using turbulent flow online extraction and tandem mass spectrometry

(2007) Wei Zeng et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS